Crinetics Pharmaceuticals, Inc.

Home » Crinetics Pharmaceuticals, Inc.

IPO

Crinetics Pharmaceuticals, Inc.

We are a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Symbol

CRNX

Price Range
$15.00 - $17.00

Final Shares
5,000,000

Anticipated Date
TBD

Underwriters
J.P. Morgan, Leerink Partners, Piper Jaffray

To view the prospectus for Crinetics Pharmaceuticals, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253